News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
392,396 Results
Type
Article (29362)
Company Profile (111)
Press Release (362923)
Multimedia
Podcasts (40)
Webinars (7)
Section
Business (109987)
Career Advice (1817)
Deals (18159)
Drug Delivery (82)
Drug Development (52258)
Employer Resources (142)
FDA (9970)
Job Trends (9270)
News (190970)
Policy (17435)
Tag
Academia (1996)
Accelerated approval (3)
Adcomms (22)
Allergies (63)
Alliances (28836)
ALS (71)
Alzheimer's disease (1001)
Antibody-drug conjugate (ADC) (105)
Approvals (9976)
Artificial intelligence (220)
Autoimmune disease (19)
Automation (14)
Bankruptcy (150)
Best Places to Work (7892)
BIOSECURE Act (15)
Biosimilars (86)
Biotechnology (79)
Bladder cancer (74)
Brain cancer (26)
Breast cancer (224)
Cancer (1882)
Cardiovascular disease (154)
Career advice (1515)
Career pathing (27)
CAR-T (117)
Cell therapy (311)
Cervical cancer (18)
Clinical research (42373)
Collaboration (638)
Compensation (138)
Complete response letters (14)
COVID-19 (2094)
CRISPR (31)
C-suite (161)
Cystic fibrosis (65)
Data (1901)
Decentralized trials (2)
Denatured (7)
Depression (41)
Diabetes (208)
Diagnostics (4756)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (35)
Drug discovery (94)
Drug pricing (93)
Drug shortages (19)
Duchenne muscular dystrophy (73)
Earnings (47999)
Editorial (36)
Employer branding (20)
Employer resources (120)
Events (51620)
Executive appointments (444)
FDA (10940)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (5)
Funding (500)
Gene editing (89)
Generative AI (20)
Gene therapy (243)
GLP-1 (563)
Government (2995)
Grass and pollen (5)
Guidances (88)
Healthcare (12545)
Huntington's disease (16)
IgA nephropathy (25)
Immunology and inflammation (94)
Indications (23)
Infectious disease (2216)
Inflammatory bowel disease (109)
Inflation Reduction Act (9)
Influenza (43)
Intellectual property (67)
Interviews (340)
IPO (8122)
IRA (34)
Job creations (1689)
Job search strategy (1258)
Kidney cancer (11)
Labor market (32)
Layoffs (254)
Leadership (19)
Legal (3021)
Liver cancer (56)
Lung cancer (258)
Lymphoma (123)
Machine learning (6)
Management (44)
Manufacturing (249)
MASH (55)
Medical device (8027)
Medtech (8030)
Mergers & acquisitions (10389)
Metabolic disorders (563)
Multiple sclerosis (63)
NASH (16)
Neurodegenerative disease (77)
Neuropsychiatric disorders (24)
Neuroscience (1434)
NextGen: Class of 2025 (4224)
Non-profit (3002)
Now hiring (7)
Obesity (311)
Opinion (203)
Ovarian cancer (65)
Pain (59)
Pancreatic cancer (69)
Parkinson's disease (112)
Partnered (16)
Patents (122)
Patient recruitment (70)
Peanut (35)
People (27411)
Pharmaceutical (23)
Pharmacy benefit managers (19)
Phase I (13079)
Phase II (18609)
Phase III (14668)
Pipeline (1105)
Policy (113)
Postmarket research (1569)
Preclinical (5567)
Press Release (50)
Prostate cancer (90)
Psychedelics (25)
Radiopharmaceuticals (206)
Rare diseases (309)
Real estate (3304)
Recruiting (59)
Regulatory (12920)
Reports (32)
Research institute (1716)
Resumes & cover letters (314)
Rett syndrome (4)
RNA editing (3)
RSV (43)
Schizophrenia (55)
Series A (93)
Series B (63)
Service/supplier (5)
Sickle cell disease (45)
Special edition (14)
Spinal muscular atrophy (87)
Sponsored (26)
Startups (2000)
State (2)
Stomach cancer (7)
Supply chain (61)
Tariffs (30)
The Weekly (33)
Vaccines (591)
Venture capitalists (25)
Weight loss (211)
Women's health (19)
Worklife (18)
Date
Today (102)
Last 7 days (522)
Last 30 days (1911)
Last 365 days (22318)
2025 (7572)
2024 (23624)
2023 (26327)
2022 (35283)
2021 (37082)
2020 (35133)
2019 (30694)
2018 (22724)
2017 (20257)
2016 (19103)
2015 (21778)
2014 (15513)
2013 (12080)
2012 (13185)
2011 (13581)
2010 (11542)
Location
Africa (554)
Alabama (28)
Alaska (5)
Arizona (87)
Arkansas (10)
Asia (24562)
Australia (4171)
California (4023)
Canada (1244)
China (404)
Colorado (182)
Connecticut (177)
Delaware (110)
Europe (56734)
Florida (610)
Georgia (135)
Idaho (29)
Illinois (348)
India (20)
Indiana (222)
Iowa (6)
Japan (133)
Kansas (49)
Kentucky (18)
Louisiana (9)
Maine (31)
Maryland (538)
Massachusetts (2969)
Michigan (142)
Minnesota (239)
Mississippi (2)
Missouri (64)
Montana (23)
Nebraska (14)
Nevada (32)
New Hampshire (47)
New Jersey (1210)
New Mexico (21)
New York (1169)
North Carolina (671)
North Dakota (8)
Northern California (1780)
Ohio (137)
Oklahoma (13)
Oregon (26)
Pennsylvania (838)
Puerto Rico (9)
Rhode Island (21)
South America (800)
South Carolina (14)
Southern California (1492)
Tennessee (72)
Texas (630)
United States (15141)
Utah (139)
Virginia (102)
Washington D.C. (43)
Washington State (341)
West Virginia (3)
Wisconsin (43)
392,396 Results for "cambrex high point".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina
Cambrex announced the completion of its $38 million capacity expansion at its small molecule active pharmaceutical ingredient manufacturing facility in High Point, North Carolina.
October 2, 2023
·
2 min read
Press Releases
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems
May 1, 2025
·
6 min read
Pharm Country
Cambrex Completes First Phase of $30 Million Capacity Expansion Project in High Point, North Carolina
Cambrex announced the completion of the first phase of its $30 million investment in its small molecule active pharmaceutical ingredient manufacturing facility in High Point, North Carolina.
September 1, 2022
·
2 min read
Press Releases
Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing
December 6, 2024
·
2 min read
Pharm Country
Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule
Cambrex, a leading global contract development and manufacturing organization, announced that it is nearing the completion of a 5-year, $100-million-dollar investment strategy, one year ahead of schedule.
March 18, 2024
·
2 min read
glp-1
Novo Nordisk Links High-Dose Wegovy to Increased Weight Loss in Phase III Trial
The data suggest the high dose nearly closes the efficacy gap with Zepbound.
January 17, 2025
·
3 min read
·
Nick Paul Taylor
Press Releases
AVAVA™ Receives FDA Clearance for Revolutionary Acne Scar Treatment using Focal Point Technology™
April 22, 2025
·
3 min read
Earnings
Bluebird Faces Cash Gap With Breakeven Point in Sight
Bluebird has just two quarters until it’s out of cash. Executives are looking for financing to extend that runway to a projected breakeven point before the end of 2025, with analysts worried they won’t make it.
November 15, 2024
·
4 min read
·
Annalee Armstrong
Press Releases
Cambrex Opens New Stability Storage Facility in Durham, North Carolina
October 17, 2024
·
2 min read
Press Releases
Johnson & Johnson’s TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC
April 28, 2025
·
10 min read
1 of 39,240
Next
